explore -WSS

explore

author：Wikipedia 2025-09-27 19:01:47 - browse：89122

Vertex Pharmaceuticals - sunset — Bill Sikes/AP

LONDON — Regulators in the U.K. on Thursday approved a CRISPR-based medicine to treat both sickle cell disease and beta thalassemia, making it the world’s first therapy built on the revolutionary gene-editing technology and ushering in a new era of genetic medicine.

The authorization of the therapy, from Vertex Pharmaceuticals and CRISPR Therapeutics, is itself not a surprise. Clinical trials have shown the one-time treatment enabled many sickle cell patients to live free of debilitating pain crises and relieved thalassemia patients of needing regular blood transfusions, raising hopes that they have been effectively cured. But it also stands as a major achievement, coming just over a decade after the first and seminal lab experiments that showed CRISPR’s potential as a gene-editing tool were published.

In granting conditional approval to the therapy, which will have the brand name Casgevy and is also known as exa-cel, the U.K.’s Medicines and Healthcare products Regulatory Agency jumped ahead of its counterparts in the U.S. and Europe, which are also reviewing the medicine, in greenlighting the globe’s first CRISPR treatment. The MHRA’s authorization is for patients who are at least 12 years old.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： National panel will explore requiring free Covid tests

WSS

What the US credit downgrade means for the economy, your finances

‘Oppenheimer’ and the risks of AI in health care

What to expect as Trump is arraigned on his Jan 6. indictment

Nurses recount patients attacks

Asbestos, a deadly carcinogen, banned by EPA

Intermittent fasting comes with a heart risk? Not so fast

hotspot

explore

entertainment

Tori Bowie and the unacceptable rates of Black maternal death

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Stop the failed accountable care organization experiment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Guidelines to prevent youth baseball injuries need more muscle

Future doctors should be trained to promote social change

Supreme Court strikes down use of affirmative action

Health AI adoption puts security, privacy startups on investors' radar

leisure time

Plastic surgeons increase patient psychiatric screenings

Micronoma's microbiome cancer diagnostic approach under fire

No plane should take off without an EpiPen onboard

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Sage hopes for a blockbuster in antidepressant now before FDA

SCOTUS questions limit to govt efforts to fight misinformation

leisure time

leisure time

Wikipedia

focus